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of the malaria parasite Plasmodium
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Centre for Mathematics and the Environment, University of Exeter, Penryn Campus, Penryn TR10 9EZ, UK
Infection by the human malaria parasite Plasmodium falciparum results in a
broad spectrum of clinical outcomes, ranging from severe and potentially
life-threatening malaria to asymptomatic carriage. In a process of naturally
acquired immunity, individuals living in malaria-endemic regions build up
a level of clinical protection, which attenuates infection severity in an
exposure-dependent manner. Underlying this shift in the immunoepidemiol-
ogy as well as the observed range inmalaria pathogenesis is the varmultigene
family and the phenotypic diversity embedded within. The var gene-encoded
surface proteins Plasmodium falciparum erythrocyte membrane protein 1 med-
iate variant-specific binding of infected red blood cells to a diverse set of host
receptors that has been linked to specific disease manifestations, including
cerebral and pregnancy-associated malaria. Here, we show that cross-reactive
immune responses, which minimize the within-host benefit of each addition-
ally expressed gene during infection, can cause selection for maximum
phenotypic diversity at the genome level. We further show that differential
functional constraints on protein diversification stably maintain uneven
ratios between phenotypic groups, in line with empirical observation. Our
results thus suggest that the maintenance of phenotypic diversity within
P. falciparum is driven by an evolutionary trade-off that optimizes between
within-host parasite fitness and between-host selection pressure.1. Introduction
Plasmodium falciparum is the most virulent human malaria parasite. A key viru-
lence determinant is the ability of infected red blood cells to bind to a variety of
host receptors, causing sequestration in the deep vasculature and obstruction of
blood flow in vital organs. Cytoadhesion is mediated by the highly poly-
morphic Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1),
expressed on the surface of infected red cells and encoded by the var multigene
family [1–4]. These proteins are also prominent targets for host immune
responses, and each parasite genome contains a different repertoire of 60
var genes, of which only one gene is actively transcribed at a time. In a process
known as clonal antigenic variation, parasites switch expression between
individual var genes in a mutually exclusive fashion, causing new variants to
appear over the course of an infection [5,6].
Different PfEMP1 variants bind to different host receptors [3] and can lead
to parasite sequestration in different host tissues, such as the brain or placenta
[7]. Probably, the best known example of this is the involvement of var2csa in
pregnancy-associated malaria, which can be found in every var gene repertoire
sequenced to date and whose protein product (VAR2CSA) binds exclusively to
placental CSA, leading to severe complications during pregnancy [8]. Therefore,
in vivo antigenic variation not only aids immune evasion, but can also evoke
temporal changes in the phenotypic profile of the parasite population during
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2infection, with important consequences for infection outcome.
Note, for the purpose of this work, we refer to phenotype
or phenotypic group, as a subset of var genes with similar
binding characteristics.
Although hosts living in malaria-endemic areas may
never attain a state of sterile immunity, they acquire a broad
spectrum of PfEMP1-specific antibodies with repeated
exposure [9–12]. This has been shown to attenuate infection
severity, such that severe and fatal malaria is usually confi-
ned to the youngest age groups, whereas older individuals
only rarely experience clinical malaria episodes [13]. Under-
lying this transition in the immunoepidemiology of
P. falciparum malaria appears to be a qualitative change in
var gene expression during infection mediated by the host’s
immune repertoire [14,15], indicating an exposure-mediated
link between acquired immunity, phenotype selection and
malaria pathology.
Despite their enormous sequence diversity, var genes can
be grouped according upstream promoter sequence (Ups) or
chromosomal location, with a remarkably conserved distri-
bution of these groups within parasite repertoires [16,17].
This conserved partitioning appears to be facilitated by recom-
bination being largely confined to within groups, meaning
that groups may be evolving independently of one another
[7,18]. Furthermore, these genetically defined groups seem
to associate with binding phenotype [19], which suggests
that P. falciparum parasites have not only evolved to maximize
antigenic diversity, but also evolved a mechanism by which
they maintain phenotypic diversity within their repertoires
of antigen encoding and virulence-associated genes.
While the evolutionary forces that favour phenotypically
diverse antigen repertoires remain largely unknown, the cen-
tral role that PfEMP1 plays in acquired immunity and
immune evasion makes selection by the immune system a
likely candidate. Previous work exploring the effects of
immune selection predominantly focused on between-host
interactions and predicted that parasite populations will
self-organize into antigenically discordant strains, thereby
minimizing the detrimental effect of previous exposures on
subsequent infections owing to cross-immunity [20]. The
highly conserved partitioning of var gene repertoires, which
has also been shown to restrict the number of unique antigen
combinations and thus only poorly uses the available global
pool of antigenic variants [21], is difficult to reconcile with
this hypothesis, however.
More recently, we have postulated how evolutionary
trade-offs at multiple ecological levels (within-host and
within-populations) can explain observed distributions of
var genes and gene domains with respect to their degree of
sequence conservation [22]. Crucially, while this framework
explored the evolution of gene and domain distributions
within already partitioned repertoires, it did not address
why parasites should encode multiple phenotypic groups,
rather than evolving into separate and independently
transmissible phenotypes.
Here, using an evolutionary framework, we show how a
trade-off between within-host fitness and between-host selec-
tion pressure can robustly select for phenotypically diverse
antigen repertoires. Furthermore, we show that functional
constraints that limit the degree by which different pheno-
types can diversify without losing binding functionality are
sufficient to explain observed var gene repertoire structures
in P. falciparum.2. Methods
We developed a stochastic, individual-based model to investigate
the evolutionary factors that select for phenotypically diverse anti-
gen repertoires. We defined parasites strains by their antigenic
repertoire, which itself comprised up to two phenotypic groups.
That is, each repertoire was made up of antigenic variants of
either phenotype A or phenotype B. We assumed that all strains
have the same repertoire size, referred to as r, but could differ in
the number of variants belonging to either group A or B. We
refer to a particular repertoire structure as (A : B), indicating the
ratio of antigens within the repertoire belonging to phenotype
A or phenotype B. Note, repertoire structure can be considered as
a collective term, referring to all strains with the same distribution
of genes of type A and type B.
Owing to the high dimensionality of the potential antigenic
space that can be generated simply through recombination of
the global pool of antigenic variants, we investigated gene reper-
toire evolution by repeatedly simulating population infection
histories with a fixed set of parasite strains. At the beginning
of each simulation, we initialized the parasite population to con-
tain exactly one member of every possible repertoire structure
(i.e. one of each (r : 0), (r2 1 : 1), . . . , (0 : r)) and filled the reper-
toires by randomly sampling from the two global variant pools
(of sizes NA and NB). Each simulation was run until it reached
a dynamic equilibrium (around 10 000 simulated days), at
which point all but a small subset of strains are driven to extinc-
tion. We refer to those strains that are maintained within the
population as ‘dominant’, irrespective of their population-level
prevalence. That is, dominance is here defined as a purely quali-
tative measure referring to those strains that have competitively
excluded all other strains.
For the majority of simulations, we restricted the genomic
repertoire sizes to r ¼ 9 and antigenic pool sizes to NA ¼ 13
and NB ¼ 13, which are all significantly smaller than the
assumed diversity of var genes both within individual repertoires
and at the population level. These numbers were chosen for com-
putational reasons only (larger numbers take significantly longer
to converge), however, and we note that our results were inde-
pendent of repertoire and global variant pool sizes. Examples
of larger repertoire and variant pool sizes can be found in
electronic supplementary material, figure S1.
Hosts are modelled individually with the host popula-
tion being kept constant at 10 000 and deaths being replaced by
newborns. Host mortality was assumed to be age-dependent,
given as
pdeathðTÞ ¼ 0:002e
0:07T
365
, ð2:1Þ
where T is the host age in years. We ignored maternal protection
and further assumed that infections do not contribute to death.
At the start of each simulation, hosts are initialized such that
the population is demographically at equilibrium.
For the sake of simplicity, we kept the total rate of infection
constant over time and instead assumed transmission to be
solely frequency dependent, where the (daily) probability of a
host getting infected with strain i depends only on the relative
frequency of strain i in the population. The daily infection rate
of strain i can then be given as
piinf ¼ l0
piP
j pj
, ð2:2Þ
where l0 ¼ 0.033 is the daily force of infection and pi is the
proportion of hosts currently infected with strain i.
Upon infection, it was assumed that the infecting strain will
express its antigenic repertoire in a random order, where each
variant contributes positively to infection length. Hosts acquire
immunity in a variant-specific manner, which prevents the
specific variant from contributing to future infections. In this
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3fashion, hosts might acquire full immunity to a particular strain
without necessarily having been exposed to it. Where cross-
immunity is considered, not all variant genes will contribute
equally to infection length, in which case variant-specific immu-
nity is acquired probabilistically and in proportion to their
contribution to infection length, L.
Within this framework, a strain’s fitness solely refers to infec-
tion length and is therefore not a fixed quantity, but dependent
on the immune repertoire of the host it currently infects. Infection
length was determined by the number of novel antigens the infect-
ing strain presents to the host, with no explicit assumptions about
expression order and no intrinsic differences between the two
phenotypic groups. This might be seen in slight deviation from
hypothesized fitness differences between UpsA and UpsB/C var
genes, for example, where the former is often observed to domi-
nate infections in young and immunologically naive hosts.
However, by assuming an equal contribution by all variants, inde-
pendent of phenotype, we create a more robust null-model, which
does not rely on specific gene expression orders or growth rate
differences in differently pre-exposed hosts.
With regards to immune interactions, we considered three
different scenarios (i) variant-specific immunity only, (ii) pheno-
type-specific cross-immunity, and (iii) phenotype-transcending
cross-immunity.2.1. No cross-immunity
In the absence of any immune interactions, i.e. where immunity is
solely variant-specific, we can define the length of infection, Ln,
simply by a linear function of the number of novel antigens of
type A and B (nA and nB, respectively), which in its simplest
form could just be given as
Ln ¼ LA þ LB ¼ l0ðnA þ nBÞ, ð2:3Þ
with l0 being the contribution of each antigen to infection length.
As mentioned above, we did not assume any intrinsic difference
between genes or phenotypes with regards to growth rate or
immunogenicity, so each variant gene contributes equally to
total infection length.2.2. Phenotype-specific cross-immunity
We argued that antigens belonging to the same phenotype will
have higher sequence similarities, and hence antigenic simi-
larities, than antigens binding to different host receptors. We
therefore considered the case whereby phenotype-specific
cross-reactive immune responses would build up during the
infection, which, in turn, would reduce the contribution of
each additionally expressed variant—of the same phenotype—to
infection length. The total infection length is then governed by
a law of diminishing returns, given as
Ls ¼ LA þ LB ¼
XnA1
j¼0
l0ejs þ
XnB1
k¼0
l0ejs and ð2:4Þ
¼ l0 1 e
nAs
1 es þ
1 enBs
1 es
 
, ð2:5Þ
with s being the degree of cross-reactivity (s [ ½0, 1). For most
of this work, we assumed cross-immunity to be transient and
reset to zero between consecutive infections; this was later
relaxed, however, without changing the qualitative nature of
our results.2.3. Phenotype-transcending cross-immunity
Finally, we also considered the case where cross-immunity
would build up during the infection in relation to any antigen
presented, i.e. independent of their phenotypic group. In thiscase, the total infection length can be calculated as
Lt ¼
XnAþnB1
i¼0
l0eis ¼ l0 1 e
ðnAþnBÞs
1 es : ð2:6Þ
In order to investigate the robustness of evolved repertoire
structures under different contributions of phenotype-specific
and phenotype-transcending cross-immunity, we defined
G :¼ l0
XnB1
j¼0
ejs 
XnAþnB1
i¼nAþ1
eis
0
@
1
A, ð2:7Þ
such that the infection length under the consideration of both
phenotype-specific and phenotype-transcending cross-immunity
becomes
Lc ¼
XnA1
j¼0
l0ejs þ
XnB1
k¼0
l0ejs  dG and ð2:8Þ
¼ LA þ LB  dG: ð2:9Þ
Therefore, d ¼ 0 corresponds to phenotype-specific cross-
immunity only and d ¼ 1 corresponds to phenotype-transcending
cross-immunity. Equally, setting s ¼ 0 recovers the infection
length considering no cross-immunity at all.3. Results
3.1. Variant-specific immunity selects against
phenotypic diversity
We first considered the case where host immunity is solely
variant-specific, such that infection length is linearly corre-
lated with the number of novel variants a parasite strain
presents to its host (see Methods). Previous theory predicts
that immune selection can cause parasite populations to
organize into sets of dominant strains with minimal antigenic
similarity. In this case, the immune responses induced by
these strains cover a sufficiently large part of the available
antigenic diversity to suppress the emergence or invasion
of other (recombinant) strains [20,23]. We find a similar
behaviour in our model system, where pairs of strains con-
sisting of two homogeneous repertoires containing only one
or the other phenotype, i.e. with a (phenotype A : phenotype
B) repertoire structure of (r : 0) and (0 : r), which by definition
share no antigen variants, more often end up being dominant
with all other strains competitively excluded. Note that
we consider a strain to be dominant if it is not extinct by
t ¼ 10 000. An example time series of this scenario is shown
in figure 1a, where strains with phenotypically heterogeneous
repertoires are driven to extinction and a set of strains with
repertoire structures (r : 0) and (0 : r), and hence no antigenic
overlap, become dominant.
Although the particular outcome of each simulation with
respect to the repertoire structure that ends up dominating
the population is highly stochastic and strongly dependent
on the initial composition of strains, we find that on average
strains whose repertoires are more biased towards one pheno-
type or another have a significant competitive advantage,
simply because the chance of antigenic overlap between their
respective repertoires is minimal compared with strains with
a more even distribution of phenotypes within their repertoire.
In other words, as strains become more balanced in terms of
their antigens belonging to one or the other phenotypic
group, the chance of overlap between them increases. This,
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Figure 1. Default model behaviour under variant-specific immunity only. (a) Time series of a single model run show the changing prevalence of strains with
differently structured repertoires, with strains coloured according to their repertoire structure (A : B). Phenotypically diverse strains are driven to extinction as a
pair of strains consisting of only one or the other phenotype (i.e. with repertoire structures (9 : 0) and (0 : 9)) start to dominate. (b) Bar graph of the frequency
by which different repertoire structures dominate the population, based on 10 000 model runs, shows how phenotypically less diverse parasites are favoured under
variant-specific immunity. Stacked bars are used to visually represent within-repertoire phenotype distribution. Other parameter values: r ¼ 9, NA ¼ 13, NB ¼ 13.
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4on the other hand, reduces their population-level fitness as
infection by one strain is more likely to induce partial immu-
nity to another. This is shown in figure 1b, where we used
average dominance frequency as an estimate of the (popu-
lation-level) fitness of a particular repertoire structure. As
mentioned in Methods, dominance is a qualitative measure
referring to a strain or set of strains that is maintained in the
population and has competitively excluded all other strains,
as exemplified in figure 1a.3.2. Phenotype-specific cross-immunity selects for
partitioned gene repertoires
An important part of immune protection in malaria is the
ability of anti-PfEMP1 antibodies to inhibit and potentially
reverse binding of the infected red cells to host receptors
[24,25]. It is therefore conceivable that antibodies raised
against a variant of one phenotype should exhibit some
cross-inhibition of binding of other variants of the same
phenotype, but not necessarily inhibit the binding of variants
that target a different host receptor. We therefore examined
the effects of phenotype-specific cross-immunity on var
gene repertoire evolution by further assuming that cross-
immunity accumulates over the course of infection with
each expressed variant of the same type. This, in turn,
reduces the contribution of every additionally expressed var-
iant to infection length, resulting in the total infection length,
Ln, in relation to the number of novel antigens exposed to the
host, being governed by a law of diminishing returns (see
Methods for more details).
Depending on the degree of cross-immunity, s, we note
that a strain’s infection length, even in naive hosts, quickly
plateaus with the number of expressed variants, as shown
in figure 2a, implying there is an upper limit to the length
of an infection which cannot notably be extended by expres-
sing additional variants of the same phenotype. Crucially,
however, this limitation can be circumvented by the parasite
by expressing members of an alternative phenotypic group.Under the addition of phenotype-specific cross-immu-
nity, antigen repertoires now experience selection pressure
by two conflicting forces. At the population level, the
pressure to reduce the probability of encountering hosts
with prior immunity selects for homogeneous repertoire
structures and low phenotypic diversity, which minimizes
antigenic overlap with other strains (as shown above,
figure 1). At the level of individual infections, on the other
hand, repertoires are under selection pressure to maximize
infection length, which is best satisfied by having phenotypi-
cally diverse repertoires containing equal numbers of each
phenotypic group. As a result, under moderate-to-high
degrees of cross-immunity, s, we now find phenotypically
diverse strains dominating the population, as shown by an
example time series and repertoire structure dominance
frequency in figure 2b and c, respectively.
To further understand and illustrate the evolution of differ-
ent repertoire structures under changes in the degree of cross-
immunity, we can calculate the relative fitness of a particular
strain by means of its infection length in a host previously
infected by any of the other strains. For illustration purposes
only, we restrict the analysis to a limited antigenic pool
where the total number of variants of phenotype A or B
equals the parasite’s repertoire size, such that a pair of pheno-
typically homogeneous strains would completely exhaust the
available antigenic space. The matrix plots in figure 3 show
the infection length of strain i in a host with previous exposure
to strain j for all (i,j)-pairs, which clearly demonstrate how
phenotypically diverse repertoires start to gain a competitive
advantage as the degree of cross-immunity increases (from
s ¼ 0, (a), to s ¼ 0.7, (d)), leading to their preferred selection
and dominance within the population.
Importantly, the selection of phenotypically diverse
strains is robust to parameter changes in host population
sizes, repertoire size, force of infection and antigen expression
order and further persists, regardless of whether we assume
cross-reactive immunity to be transient and lost between
infections or whether it is permanent and accumulates over
repeated infections (shown in electronic supplementary
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Figure 2. Cross-immunity selects for phenotypically diverse repertoires.
(a) Total infection length as a function of the number of antigenic variants
presented over the course of infection, c, under variation in the degree of
cross-immunity, s. For high levels of cross-immunity, infection length
starts to plateau well before the parasite can exhaust its antigenic repertoire
and additionally expressed genes will not contribute to further infection
length. (b) Time series of a single model run with temporary cross-immunity
(s ¼ 0.3) showing the competitive exclusion of phenotypically uniform
parasites (blue lines) in favour of strains containing partitioned and hence
phenotypically diverse repertoires (red and purple lines). (c) Bar graph of
the average strain dominance frequency based on 10 000 model runs
shows how phenotypically diverse strains gain a selective advantage under
phenotype-specific cross-immunity (s ¼ 0.3). Stacked bars are used to
visually represent within-repertoire phenotype distribution. Other parameter
values: r ¼ 9, NA ¼ 13, NB ¼ 13.
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5material, figures S1–S5). We also tested the robustness of
these results by relaxing our assumption of cross-immunity
to be restricted to the respective phenotypes (see Methods).
We now find that as cross-immunity shifts away from being
confined to variants of the same phenotype to become
more predominantly phenotype transcending, parasiterepertoires become phenotypically less diverse. As shown in
electronic supplementary material, figure S4, even moderate-
to-high degrees of phenotype-transcending immunity
can select for within-repertoire phenotypic diversity as long
as there is a non-negligible degree of phenotype-specific
cross-immunity.
3.3. Functional constraints influence repertoire
partitioning
Data from fully sequenced var gene repertoires reveal a con-
served structure with very uneven group sizes. We
therefore investigated possible conditions that could offer
an evolutionary advantage of skewed phenotype distri-
butions, concentrating again on the functionality of PfEMP1
in terms of receptor binding.
It can be argued that the evolution and diversification of
PfEMP1 variants is constrained by the necessity to retain
functional binding to their target receptors. It is further poss-
ible that different binding phenotypes, which target different
host receptors, are constrained to different degrees, for
example, owing to the specific structural characteristics of
the binding targets. On the one hand, this may limit the
global antigenic diversity of each phenotype to a different
degree, i.e. resulting in different global pool sizes NA and
NB. On the other hand, it may result in different degrees of
cross-reactive inhibition experienced by variants of each
phenotype, i.e. where the degree of cross-immunity, s,
becomes phenotype-specific (sA and sB).
We first examined the influence of global antigen diver-
sity on the repertoire partitioning structure by considering
differently sized antigen pools of the two phenotypic
groups a and b. We note that by increasing the size of one
phenotype’s antigen pool, the likelihood of overlaps within
a particular phenotype group decreases. In the absence of
cross-immunity, this results in a competitive advantage to
repertoire structures that use larger numbers of this (more
diverse) phenotype (figure 4a). With the addition of cross-
reactive immunity, the extent to which large numbers of
antigens from this phenotype group can be usefully exploited
is curtailed, however. This results in a skewed distribution in
repertoire structure dominance frequency, where homo-
geneous repertoire structures (with low phenotypic
diversity) are strongly disadvantaged while moderately
heterogeneous repertoires with a bias towards the more
diverse phenotype group are favoured (figure 4b).
Next, we considered differential degrees by which anti-
bodies can inhibit PfEMP1 binding in a phenotype-specific
manner. We argued that because PfEMP1 is a modular
protein, distinct variants may still share whole domains or
exhibit regions of high similarity between domains. Further-
more, domains can be organized into motifs comprised of
specific domain subclasses in tandem that are commonly
referred to as domain cassettes. The above-mentioned
functional constrains on domain diversity together with
observed correlations between groups of domain subclasses,
which may act as functional units, could limit the number
of antigenically distinct binding epitopes and thus increase
the degree of cross-reactivity within variants containing
similar domains. Broad inhibitory cross-reactivity at the
domain/domain cassette level has been shown previously
[25] and while we do not model the domain-level struc-
ture of PfEMP1 explicitly, we incorporated differences in
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Figure 3. Pairwise and mean infection length under changes in cross-immunity. (a–d) Matrix plots show the (i,j ) pairwise infection lengths, resulting from an infection
of strain i in a host previously exposed to strain j. The bar graphs depict the mean infection length of each repertoire structure (represented as stacked bars to represent
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the qualitative change in repertoire fitness. (a) s ¼ 0, (b) s ¼ 0.1, (c) s ¼ 0.3, (d ) s ¼ 0.7. Other parameter values: r ¼ 9, NA ¼ 9, NB ¼ 9.
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6cross-reactivity by using phenotype-specific values of s. The
results are similar to those obtained by considering different
antigenic pool sizes, leading to skewed phenotype distri-
butions whereby strains with moderately heterogeneousrepertoires can be seen to enjoy an evolutionary advantage,
resulting in frequent selection and dominance in the popu-
lation (figure 4c), in line with empirical observations (inset
in figure 4b).
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Figure 4. Functional constraints on PfEMP1 select for skewed phenotype
distributions. Bar graphs show the average strain dominance frequencies
based on 10 000 model runs, with stacked bars used to represent within-
repertoire phenotype distribution. (a) Considering different antigenic pool
sizes of phenotypes A and B (NA ¼ 36 and NB ¼ 9) with variant-specific
immunity only selects for parasites with mono-phenotypic repertoires.
(b) Including cross-immunity (s ¼ 0.1) restricts the benefit of expressing
more variants of the same phenotype, leading to the evolution of pheno-
typically diverse repertoires skewed towards the more diverse phenotype
(A). The inset shows the repertoire distribution of UpsA versus non-UpsA
var genes in seven sequenced P. falciparum isolates, shows a skewed and
conserved repertoire partitioning. (c) Differences in the degree of cross-reac-
tivity, with sA ¼ 0.1 and sB ¼ 0.8, has the same effect as different
antigenic pool sizes and select for repertoires with uneven numbers of
phenotypic variants. Other parameter values: r ¼ 9.
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74. Discussion
The highly immunogenic nature of the var gene-encoded
malaria virulence factors PfEMP1 makes them importanttargets for host protective immune responses and therefore
subject to intense selection pressure. Previous theoretical
work on the evolution of var gene repertoires has predicted
that strong immune selection will act to structure the parasite
population into strains with minimal antigenic similarity [20],
such that an infection by one strain has little or no detrimen-
tal impact on the fitness of subsequently infecting strains.
Since then, further empirical work on var genes and var
gene repertoires has highlighted a conserved genomic struc-
turing, whereby gene repertoires are not just random
collections of antigenic variants, but contain distinct groups
of genes differentiated for example by their genomic location,
upstream promoter sequence, number of binding domains or
even sequence diversity [6,17,22]. These characteristics are
interrelated, however, and there appears to be some mechan-
ism in place that maintains the observed repertoire structure
over evolutionary time [26] despite high rates of recombina-
tion. This, on the other hand, strongly suggests that gene
repertoires containing distinct groups of genes have a com-
petitive advantage despite the poor utilization of the
globally antigenic diversity this entails [21], especially when
considering that the ratios of genes belonging to the different
groups also appear highly conserved [6,16,17].
In line with previous predictions, we found that variant-
specific immune responses can select for parasite strains
withminimally overlapping antigenic repertoires. Considering
that antigenic variants can be of two different phenotypes, this
implied an evolutionary trend towards the dominance of pairs
of strains comprising variants of only one or the other pheno-
type. We note that this particular outcome was partly driven
by our model set-up to contain one representative strain of
every possible repertoire structure. In this case, two strains
whose repertoires contained variants of only one or the
other phenotypic group will be (antigenically) non-overlap-
ping by default, whereas the probability that two strains
containing variants of both phenotypic groups have overlap-
ping repertoires increases as the phenotype distribution
becomesmore even. On the other extreme, when we initialized
themodel such that each strain has a non-overlapping counter-
part, there are no longer population-level fitness differences
and all strains will be equally likely to become dominant.
One way or the other, this clearly illustrates that variant-
specific immunity alone cannot account for the empirically
observed phenotypic diversity within var gene repertoires.
We therefore concentrated on the functional importance of
PfEMP1, i.e. adhesion to host cell receptors, as a potential factor
in P. falciparum evolution. Because of its crucial contribution to
within-host parasite fitness, by removing the infected red cells
from circulation and thus avoiding clearance by the spleen, we
argued that (antigenic) diversification of PfEMP1 may be lim-
ited for the protein to retain functional viability, andwe further
argued that this limitation would increase the chance of anti-
body-mediated cross-inhibition of parasite binding. The
presence of transient cross-reactive immune responses has
been well established in longitudinal studies [27,28], although
whether these are specific to particular phenotypes or not is
not yet clear. More recent work has confirmed the presence
of cross-reactive immunity between variants with specific
binding phenotypes, for example in IgM rossetting [29], as
well as broad cross-reactivity to particular epitope regions,
such as domain cassette 4, which is associatedwith ICAM bind-
ing [25], where both binding phenotypes are associated with
severe infectionpathology. Furthermore, structural conservation
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8in EPCR-binding PfEMP1 has been shown despite large
sequence diversity [30], although the contribution this makes
to cross-reactive antibody-mediated immunity, especially over
the course of an infection, is yet to be established.
We tested two PfEMP1-binding related hypotheses for their
effect on the evolution of intragenomic repertoire partitioning:
(i) phenotype-specific differences in the degree by which the
proteins, or particular binding loci, can diversify without
losing functionality, leading to different pool sizes of antigenic
variants and (ii) phenotype-specific differences in the degree
of cross-inhibition. Both could, in fact, be argued to be part
of the sameprocess, such that a constraint onprotein diversifica-
tion might entail an increase in cross-recognition by antibodies.
In terms of their role in gene repertoire evolution, we found
that both had the same effect and caused a shift in repertoire
structuring towards biased phenotype distributions, similar
to those observed in P. falciparum. Based on features of short
sequence tags within the Duffy-binding-like a domain,
Bull et al. [31] reported similar frequency distributions of
groups of var genes within the genome as within the popu-
lation, despite them being very different in size. Similarly, it
is well known that the UpsA group of var genes exhibits less
global diversity than other groups and also comprises a rela-
tively small proportion of the var gene repertoire. The most
extreme example might be that of var2csa, whose presence in
every repertoire and unusual sequence conservation compared
with other var genes makes it an attractive vaccine target [32].
Further empirical investigations are necessary to test whether
these observations could, in fact, be due to our hypothesi-
zed functional constraints or differences in immunogenic
cross-inhibition, however.
We assumed that variant genes are being expressed sequen-
tially over the course of an infection, at least to a level
sufficiently high to trigger an immune response. Under this
assumption, each additionally expressed gene contributes posi-
tively to infection length and thus transmission probability. In
the most extreme case, this led to every variant having an
equal contribution to the length of infection and thus within-
host fitness, which is highly unlikely to be the case in real
malaria infection. On the other hand, this particular scenario
could not explain the observed repertoire structures. Once we
considered cross-immunity, this assumption was partially
relaxed and we showed that as long as individual variants
would contribute positively to within-host fitness, i.e. as long
as infection length was a monotonically increasing function of
antigens expressed during infection, the model robustly pre-
dicted evolution towards phenotypically diverse repertoirestructures. Furthermore, it is also worth mentioning that the
sequential dominance by a single or only a few antigenic
variants is thought to underlie the characteristic waves of para-
sitaemia in P. falciparum malaria [33–35]. In that respect, it is
also interesting to note that transient cross-reactive immune
responses against groups of antigenic variants sharing particu-
lar PfEMP1 epitopes have previously been proposed to
orchestrate the parasite population to exhibit the observed
single-variant dominance during infection [36]. This adds
further to the notion that cross-reactive immunity could play
a highly significant role for parasite evolution and malaria
epidemiology in general.
Another interesting consequence of transient cross-reactive
immunity is that it offers a simple explanation as to why var
gene repertoires have evolved to be limited to 60 variants.
Under variant-specific immunity alone, we would expect
either selection for vast repertoires of antigenically distinct var-
iants or the evolution of a mechanism by which diversity can
easily be generated during the course of infection, both of
which are common strategies for other antigenically variable
organisms [37]. Although high rates of mitotic recombination
in culture adapted P. falciparum isolates have recently been
reported [38], it is not yet clear if and to what degree this
could contribute to immune evasion during infection or
whether its role is more limited towards the generation of anti-
genic diversity at the population level. Therefore, the relatively
limited size of the antigenic repertoire of P. falciparum has been
a bit of a conundrum, which temporary cross-immunity could
possibly resolve, although this is purely speculative at this
stage and requires further investigation.
In summary, our results support the hypothesis that pheno-
typically diverse var gene repertories are maintained by a
combination of between-strain and within-host immune selec-
tion. A similar mechanism has recently been put forward to
underlie the sequence and domain evolution of individual
var genes and gene repertoires [22], which strongly suggests
that evolutionary trade-offs, by which the parasite has to opti-
mize between the within-host and within-population-level
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